Welcome to the Newsroom
04 June 2015
Prima BioMed to maintain NASDAQ Listing
SYDNEY, AUSTRALIA - Prima BioMed Ltd (NASDAQ: PBMD; ASX: PRR) (“Prima”, the “Company”), announces that, further to the announcement made on 29 December 2014, it has received a notice, dated 3 June 2015 from the Listing Qualifications Department of The NASDAQ Stock Market, indicating that, for the 10 consecutive business days from 19 May 2015 to 2 June 2015, the closing bid price of the Company’s American Depositary Shares has been at $1.00 per share or greater. Accordingly, the Company has regained compliance with Listing Rule 5450(a)(1) (“the Minimum Bid Price Rule”) and the Company’s shares will remain listed on The NASDAQ Global Market.
Article as pdf